(Q41121054)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jaap J. Boelens

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

19

N M Wulffraat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

L C J Te Boome

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

C Mansilla

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

L E van der Wagen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

C A Lindemans

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

E J Petersen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

K A Thus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

K Westinga

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

M Plantinga

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

M Bierings

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

A E C Broers

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

M L H Cuijpers

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

G W van Imhoff

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

J J Janssen

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

C Huisman

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

S Zeerleder

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

G Huls

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

I C M Slaper-Cortenbach

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

J Kuball

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

3 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

1839-1846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2015.89

4 March 2020

exact match

0 references

cites work

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Adult mesenchymal stem cells: a pluripotent population with multiple applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

The best endpoint for acute GVHD treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Competing risks and multistate models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

A biomarker panel for acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Elafin is a biomarker of graft-versus-host disease of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Mesenchymal stem/stromal cells induce the generation of novel IL-10-dependent regulatory dendritic cells by SOCS3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.89

Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease

21 January 2018

1 reference

12 December 2020

Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring

1 reference

12 December 2020

Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population

1 reference

12 December 2020

Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease

1 reference

12 December 2020

Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

1 reference

12 December 2020

Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).

1 reference

12 December 2020

Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype

1 reference

12 December 2020

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study

1 reference

12 December 2020

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

12 December 2020

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

1 reference

12 December 2020

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2015.89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25836589%20AND%20SRC:MED&resulttype=core&format=json